MeSH Browser

MeSH Supplementary: APO protocol 2
Unique ID: C051719
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C051719
Entry Term(s): APO regimen
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Vincristine
Frequency: 4
Note: chemotherapy protocol consisting of above compounds; used in treatment of small cell lung neoplasms
Source: Cancer Chemother Pharmacol 1986;18 Suppl 2:S40
Date of Entry: 1987/04/17
Revision Date: 2000/11/30

APO protocol 2 MeSH Supplementary Concept Data 2024